Corrigendum to “Pratensein attenuates Aβ-induced cognitive deficits in rats: Enhancement of synaptic plasticity and cholinergic function” [Fitoterapia 101 (2015) 208–217] (Fitoterapia (2015) 101 (208–217), (S0367326X15000283), (10.1016/j.fitote.2015.01.017));Pratensein attenuates Aβ-induced cognitive deficits in rats: Enhancement of synaptic plasticity and cholinergic function

Fitoterapia

Volumn 101, Issue , 2015, Pages 208-217

  Wei, Ling ^a   Lv, Shujuan ^a   Huang, Quanfang ^b   Wei, Jinbin ^a   Zhang, Shijun ^a   Huang, Renbin ^a   Lu, Zhongpeng ^b,c   Lin, Xing ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine; Cognitive impairment; Pratensein; Synapse; amyloid

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ACETYLCHOLINE; AMYLOID BETA PROTEIN[1-40]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CATHEPSIN B; CHOLINESTERASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HUPERZINE A; INSULINASE; INTERLEUKIN 1BETA; MEMBRANE METALLOENDOPEPTIDASE; NITRIC ACID; PRATENSEIN; PROTECTIVE AGENT; RED CLOVER EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 4'-METHOXY-3',5,7-TRIHYDROXYISOFLAVONE; ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); CHOLINERGIC RECEPTOR STIMULATING AGENT; ISOFLAVONE DERIVATIVE; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; AMYLOID BETA INDUCED COGNITIVE DEFICIT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN REGION; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; LATENT PERIOD; LEARNING; MALE; MEMORY DISORDER; MORRIS WATER MAZE TEST; NERVE CELL DEGENERATION; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RED CLOVER; SPATIAL MEMORY; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; CLOVER; DISEASE MODEL; DRUG EFFECTS; HIPPOCAMPUS; MAZE TEST; MEMORY; METABOLISM; WISTAR RAT;

RATTUS; TRIFOLIUM PRATENSE;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; CHOLINERGIC AGENTS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; ISOFLAVONES; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MOLECULAR STRUCTURE; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RATS, WISTAR; TRIFOLIUM;

EID: 84922503165     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2022.105123     Document Type: Erratum

References (29)

1. A.M. Palmer Pharmacotherapy for Alzheimer's disease: progress and prospects Trends Pharmacol Sci 23 2002 426 433
2. B.R. Roberts, T.M. Ryan, A.I. Bush, C.L. Masters, and J.A. Duce The role of metallobiology and amyloidβ peptides in Alzheimer's disease J Neurochem 120 2012 149 166
3. A. Nordberg Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications Biol Psychiatry 49 2001 200 210
4. H.C. Hunsberger, C.C. Rudy, S.R. Batten, G.A. Gerhardt, and M.N. Reed P301L tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathway J Neurochem 132 2015 169 182
5. V. Beck, U. Rohr, and A. Jungbauer Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy? J Steroid Biochem Mol Biol 94 2005 499 518
6. F. Occhiuto, D.R. Palumbo, S. Samperi, G. Zangla, A. Pino, and R.D. Pasquale The isoflavones mixture from Trifolium pratense L. protects HCN 1-A neurons from oxidative stress Phytother Res 23 2009 192 196
7. H. Chen, X. Wang, Z. Jin, X. Xu, J. Zhao, and Z. Xie Protective effect of isoflavones from Trifolium pratense on dopaminergic neurons Neurosci Res 62 2008 123 130
8. K. Tsuruma, T. Nakagawa, N. Morimoto, M. Minami, H. Hara, and T. Uehara Glucocorticoid modulatory element-binding protein 1 binds to initiator procaspases and inhibits ischemia-induced apoptosis and neuronal injury J Biol Chem 281 2006 11397 11404
9. S.Z. Zhong, Q.H. Ge, R. Qu, Q. Li, and S.P. Ma Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by d-galactose in ICR mice J Neurol Sci 277 2009 58 64
10. K. Blennow, M.J. de Leon, and H. Zetterberg Alzheimer's disease Lancet 368 2006 387 403
11. T.I. Kim, Y.K. Lee, S.G. Park, I.S. Choi, J.O. Ban, and H.K. Park l-Theanine, an amino acid in green tea, attenuates β-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-κB pathways Free Radic Biol Med 47 2009 1601 1610
12. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
13. A. Haque, N.L. Banik, and S.K. Ray New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimers disease: cathepsin inhibitors as potential therapeutics CNS Neurol Disord Drug Targets 7 2008 270 277
14. V. Hook, I. Schechter, H.U. Demuth, and G. Hook Alternative pathways for production of β-amyloid peptides of Alzheimer's disease Biol Chem 389 2008 993 1006
15. J. Stockley, and C. O'Neill Understanding BACE1: essential protease for amyloid-β production in Alzheimer's disease Cell Mol Life Sci 65 2008 3265 3289
16. P.T. Chen, T.Y. Liao, C.J. Hu, S.T. Wu, S.S. Wang, and R.P. Chen A highly sensitive peptide substrate for detecting two Ass-degrading enzymes: neprilysin and insulin-degrading enzyme J Neurosci Methods 190 2010 57 62
17. S. Lesné, M.T. Koh, L. Kotilinek, R. Kayed, C.G. Glabe, and A. Yang A specific amyloid-β protein assembly in the brain impairs memory Nature 440 2006 352 357
18. 2 +/calmodulin-dependent protein kinase II-dependent modifications in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor properties Neuroscience 136 2005 397 403
19. T. Ahmed, and J.U. Frey Plasticity-specific phosphorylation of CaMKII, MAP-kinases and CREB during late-LTP in rat hippocampal slices in vitro Neuropharmacology 49 2005 477 492
20. G.C. Lau, S. Saha, R. Faris, and S.J. Russek Up regulation of NMDAR1 subunit gene expression in cortical neurons via a PKA dependent pathway J Neurochem 88 2004 564 575
21. V. Cheli, M. Adrover, C. Blanco, C. Ferrari, A. Cornea, and F. Pitossi Knocking down the NMDAR1 subunit in a limited amount of neurons in the rat hippocampus impairs learning J Neurochem 97 2006 68 73
22. S. Vaynman, Z. Ying, and F. Gomez-Pinilla The select action of hippocampal calcium calmodulin protein kinase II in mediating exercise-enhanced cognitive function Neuroscience 144 2007 825 833
23. P.T. Pang, and B. Lu Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF Ageing Res Rev 3 2004 407 430
24. R. Lamprecht CREB: a message to remember Cell Mol Life Sci 55 1999 554 563
25. H.A. Bimonte, M.E. Nelson, and A.C.E. Granholm Age-related deficits as working memory load increases: relationships with growth factors Neurobiol Aging 24 2003 37 48
26. F. Gómez-Pinilla, J. Huie, Z. Ying, A. Ferguson, E. Crown, and K. Baumbauer BDNF and learning: evidence that instrumental training promotes learning within the spinal cord by up-regulating BDNF expression Neuroscience 148 2007 893 906
27. B.J. Everitt, and T.W. Robbins Central cholinergic systems and cognition Annu Rev Psychol 48 1997 649 684
28. P. Mohapel, G. Leanza, M. Kokaia, and O. Lindvall Forebrain acetylcholine regulates adult hippocampal neurogenesis and learning Neurobiol Aging 26 2005 939 946
29. K.E. Galluzzi, D.M. Appelt, and B.J. Balin Modern care for patients with Alzheimer disease: rationale for early intervention JAOA J Am Osteopath Assoc 110 2010 S37 S42